Low Risk, High Risk: Adjuvant Therapy in Resected p16+ Oropharyngeal Cancer with >/=5 Positive Ipsilateral Lymph Nodes. Nelson B, Takiar V. Int J Radiat Oncol Biol Phys 2022;114:10-11.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nelson B, Takiar V. Low Risk, High Risk: Adjuvant Therapy in Resected p16+ Oropharyngeal Cancer with >/=5 Positive Ipsilateral Lymph Nodes. Int J Radiat Oncol Biol Phys 2022;114:10-11.
PMID: 35964623